Thiel Scott, Mitchell Jennifer, Williams Jim
1 Navigant Consulting, Inc, Indianapolis IN, USA.
2 Navigant Consulting, Inc, Los Angeles, CA, USA.
J Diabetes Sci Technol. 2017 Mar;11(2):195-197. doi: 10.1177/1932296816676189. Epub 2016 Oct 26.
Diagnosis and treatment of diabetes changed little from the Middle Ages through the early 19th century, when the first chemical test for the condition was developed. In the 20th century, advances in diabetes management gained momentum with home-use diagnostic devices and mass-produced insulin. In the 21st century, technological developments around diabetes are advancing so rapidly that a small, discrete system of medical devices that serve as an artificial pancreas are now possible. In this article, we assert that medical device interoperability and cyber security are necessary preconditions for safe, effective, and reliable widespread use of the artificial pancreas system.
从中世纪到19世纪初,糖尿病的诊断和治疗变化不大,直到那时才开发出针对该病症的首个化学检测方法。在20世纪,家用诊断设备和大规模生产的胰岛素推动了糖尿病管理的进步。在21世纪,围绕糖尿病的技术发展迅速推进,以至于现在有可能出现一个小型、独立的医疗设备系统来充当人工胰腺。在本文中,我们断言医疗设备的互操作性和网络安全是人工胰腺系统安全、有效且可靠地广泛应用的必要前提条件。